AURKA and acute myeloid leukemia: Through detailed SAR and computer modeling studies, we identified quinazoline BPR1K871 as a potent dual FLT3/AURKA inhibitor with anti-proliferative activities in MOLM-13 and MV4-11 AML cell lines, with single digit nanomolar IC50.